Literature DB >> 22274860

Functions of thymic stromal lymphopoietin in immunity and disease.

Yanlu Zhang1, Baohua Zhou.   

Abstract

Thymic stromal lymphopoietin (TSLP) is an interleukin 7-like cytokine expressed mainly by epithelial cells. Current studies provide compelling evidence that TSLP is capable of activating dendritic cells to promote T helper (Th) 2 immune responses. TSLP has also been shown to directly promote Th2 differentiation of naïve CD4(+) T cell and activate natural killer T cells, basophils and other innate immune cells at the initial stage of inflammation. In addition, TSLP affects B cell maturation and activation and can also influence regulatory T (Treg) cell differentiation and development. TSLP-induced Th2 responses are associated with the pathogenesis of allergic inflammatory diseases, including atopic dermatitis, asthma, and rhinitis. Based on recent findings in humans and mouse models, TSLP might also be involved in the pathogenesis of inflammatory bowel disease and progression of cancer. In this review, we will summarize our current understanding of the biology of TSLP and highlight the important issues for future investigations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274860      PMCID: PMC3350568          DOI: 10.1007/s12026-012-8264-z

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  142 in total

1.  Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation.

Authors:  Colin Reardon; Matthias Lechmann; Anne Brüstle; Mélanie G Gareau; Naomi Shuman; Dana Philpott; Steven F Ziegler; Tak W Mak
Journal:  Immunity       Date:  2011-08-04       Impact factor: 31.745

2.  Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis.

Authors:  Mei Li; Pierre Hener; Zhikun Zhang; Shigeaki Kato; Daniel Metzger; Pierre Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

Review 3.  T regulatory cells in cancer: recent advances and therapeutic potential.

Authors:  Eyad Elkord; Erik M Alcantar-Orozco; Simon J Dovedi; Dat Q Tran; Robert E Hawkins; David E Gilham
Journal:  Expert Opin Biol Ther       Date:  2010-11       Impact factor: 4.388

4.  Induction of IL-4 expression in CD4(+) T cells by thymic stromal lymphopoietin.

Authors:  Miyuki Omori; Steven Ziegler
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

5.  Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP.

Authors:  Renata Mazzucchelli; Julie A Hixon; Rosanne Spolski; Xin Chen; Wen Qing Li; Veronica L Hall; Jami Willette-Brown; Arthur A Hurwitz; Warren J Leonard; Scott K Durum
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

Review 6.  Tumour immunity: effector response to tumour and role of the microenvironment.

Authors:  Alberto Mantovani; Pedro Romero; A Karolina Palucka; Francesco M Marincola
Journal:  Lancet       Date:  2008-02-13       Impact factor: 79.321

7.  Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment.

Authors:  Christian A J Vosshenrich; Ana Cumano; Werner Müller; James P Di Santo; Paulo Vieira
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

8.  Regulation of helminth-induced Th2 responses by thymic stromal lymphopoietin.

Authors:  Thirumalai R Ramalingam; John T Pesce; Margaret M Mentink-Kane; Satish Madala; Allen W Cheever; Michael R Comeau; Steven F Ziegler; Thomas A Wynn
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.

Authors:  Tomoki Ito; Yui-Hsi Wang; Omar Duramad; Toshiyuki Hori; Guy J Delespesse; Norihiko Watanabe; F Xiao-Feng Qin; Zhengbin Yao; Wei Cao; Yong-Jun Liu
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

10.  MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity.

Authors:  Jacqueline G Perrigoue; Steven A Saenz; Mark C Siracusa; Eric J Allenspach; Betsy C Taylor; Paul R Giacomin; Meera G Nair; Yurong Du; Colby Zaph; Nico van Rooijen; Michael R Comeau; Edward J Pearce; Terri M Laufer; David Artis
Journal:  Nat Immunol       Date:  2009-05-24       Impact factor: 25.606

View more
  30 in total

1.  STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitis.

Authors:  Matthew J Turner; Sonia DaSilva-Arnold; Na Luo; Xinyao Hu; Callah C West; Lou Sun; Christopher Hill; Joshua Bradish; Mark H Kaplan; Jeffrey B Travers; Yang Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-20       Impact factor: 4.799

2.  A new itch to scratch for TSLP.

Authors:  Matthew J Turner; Baohua Zhou
Journal:  Trends Immunol       Date:  2014-01-09       Impact factor: 16.687

3.  Inhibition of JAK/STAT pathway restrains TSLP-activated dendritic cells mediated inflammatory T helper type 2 cell response in allergic rhinitis.

Authors:  Zhaohui Shi; Weihong Jiang; Min Wang; Xiaocheng Wang; Xiaoyuan Li; Xiaodong Chen; Li Qiao
Journal:  Mol Cell Biochem       Date:  2017-02-18       Impact factor: 3.396

4.  Thymic stromal lymphopoietin signaling in CD4(+) T cells is required for TH2 memory.

Authors:  Qun Wang; Jianguang Du; Jingjing Zhu; Xiaowei Yang; Baohua Zhou
Journal:  J Allergy Clin Immunol       Date:  2014-10-24       Impact factor: 10.793

5.  Chrysophanol, an anthraquinone from AST2017-01, possesses the anti-proliferative effect through increasing p53 protein levels in human mast cells.

Authors:  Na-Ra Han; Hee-Yun Kim; Soonsik Kang; Mi Hye Kim; Kyoung Wan Yoon; Phil-Dong Moon; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  Inflamm Res       Date:  2019-05-04       Impact factor: 4.575

6.  Th9 cell development requires a BATF-regulated transcriptional network.

Authors:  Rukhsana Jabeen; Ritobrata Goswami; Olufolakemi Awe; Aishwarya Kulkarni; Evelyn T Nguyen; Andrea Attenasio; Daniel Walsh; Matthew R Olson; Myung H Kim; Robert S Tepper; Jie Sun; Chang H Kim; Elizabeth J Taparowsky; Baohua Zhou; Mark H Kaplan
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

Review 7.  Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease.

Authors:  Maya R Karta; David H Broide; Taylor A Doherty
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

Review 8.  Targeting eosinophils in allergy, inflammation and beyond.

Authors:  Patricia C Fulkerson; Marc E Rothenberg
Journal:  Nat Rev Drug Discov       Date:  2013-01-21       Impact factor: 84.694

9.  Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP.

Authors:  Weiguo Yao; Yanlu Zhang; Rukhsana Jabeen; Evelyn T Nguyen; David S Wilkes; Robert S Tepper; Mark H Kaplan; Baohua Zhou
Journal:  Immunity       Date:  2013-01-31       Impact factor: 31.745

Review 10.  Type 2 innate lymphocytes in allergic airway inflammation.

Authors:  Roel G J Klein Wolterink; Rudi W Hendriks
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.